CBS from China: ITC schedules final phase
ITC final-phase schedule for CBS rubber-accelerator AD/CVD investigations from China. Calendar, party deadlines, and AD/CVD drawback note.
The U.S. International Trade Commission scheduled the final phase of antidumping and countervailing duty investigations on N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS) from China (91 FR 65776-65777; FR Doc. 2026-21143; Inv. Nos. 701-TA-797 and 731-TA-1793 (Final)), published October 16, 2026. DATES: October 8, 2026. Issued October 13, 2026 (Lisa Barton, Secretary).
Final-phase calendar set. Hearing January 14, 2027 at 9:30 a.m. Commerce CVD prelim affirmative; Commerce AD prelim still pending. Scheduling is not an injury finding.
Product and investigation posture
CBS is an organic rubber accelerator (CAS 95-33-0; chemical formula C13H16N2S2), also known as Accelerator CZ and related trade names listed in the notice. Typically powder, oiled powder, or granule; may be imported in solution. HTSUS reference: 2934.20.80. Petitions filed May 7, 2026 by Lanxess Corporation (Pittsburgh, PA). Commerce preliminarily determined CBS from China is subsidized; Commerce's AD preliminary determination is pending. For the Commerce CVD prelim and critical-circumstances posture, see CBS China prelim CVD and critical circumstances.
Product: CBS (CAS 95-33-0) · HTSUS 2934.20.80 · petitioner Lanxess Corp. (May 7, 2026)
Commerce: CVD prelim affirmative · AD prelim pending
Hearing Jan 14, 2027 9:30 a.m. · prehearing briefs Jan 7 · appearance/APO by 21 days before hearing
Final-phase calendar
- Prehearing staff report: December 29, 2026 (nonpublic record; public version thereafter).
- Prehearing briefs: January 7, 2027.
- Requests to appear: January 8, 2027.
- Prehearing conference: January 12, 2027 at 9:30 a.m. (if deemed necessary).
- Written testimony / slides: by noon January 13, 2027.
- Hearing: January 14, 2027 at 9:30 a.m.
- Posthearing briefs and nonparty statements: January 21, 2027.
- Commission info release: February 5, 2027; final comments February 9, 2027.
Entry of appearance and APO applications: no later than 21 days prior to the hearing date. Electronic filings only via EDIS. Contact: Jack Brower, 202-205-3441.
If AD/CVD orders later issue, those duties are not drawback-eligible (19 U.S.C. 1677h). Ordinary duties on the same entries are a separate analysis. See AD/CVD drawback exclusion.
Action items
- Rubber-chemical importers and industrial users should map CBS SKUs (including solution imports and trade-name aliases) against the scope description.
- Consider party status if you have a material interest: entry of appearance / APO no later than 21 days before the January 14, 2027 hearing.
- Diary the January 2027 hearing window (briefs Jan 7, hearing Jan 14, posthearing Jan 21) and watch for Commerce's pending AD prelim.
- FR Doc. 2026-21143 (91 FR 65776-65777): ITC schedules final phase of CBS from China AD/CVD investigations (701-TA-797 and 731-TA-1793). DATES Oct 8, 2026; published Oct 16.
- CBS (CAS 95-33-0; HTSUS 2934.20.80). Petitioner: Lanxess Corporation (May 7, 2026). Commerce CVD prelim affirmative; AD prelim pending.
- Hearing January 14, 2027 at 9:30 a.m. Prehearing briefs Jan 7; appearance/APO by 21 days before hearing; posthearing briefs Jan 21.
- Electronic filings only via EDIS. Scheduling is not an injury determination.
- AD/CVD duties, if later ordered, are not drawback-eligible (19 U.S.C. 1677h).
- N-Cyclohexylbenzothiazole-2-Sulfenamide From China; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations (91 FR 65776-65777; FR Doc. 2026-21143; Inv. Nos. 701-TA-797 and 731-TA-1793 (Final)) · U.S. International Trade Commission
- Electronic Document Information System (EDIS) · U.S. International Trade Commission
This article is for general information and is not legal or tax advice. Drawback eligibility depends on your specific facts, and final refunds are determined by CBP at liquidation. Consult a licensed customs broker or attorney for your situation.